Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s):  CSCI

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone... see more

TSX:CSCI - Post Discussion

COSCIENS Biopharma Inc > Why no sharebuyback??
View:
Post by Stinzo on Oct 04, 2024 8:57am

Why no sharebuyback??

Company holds more cash then market valuation, that's assuming physical assets are worth 0.

Shareholders desperately need some breathing air. 

It seems to me to be a no brainer, use a few M to buy some shares and build some credibility ...
Comment by prophetoffactz on Oct 04, 2024 9:35am
The company is losing significant money. A lot rode on the pediatric diagnostic trial which could have provided substantial upfront, milestone and royalty payments as they drive to sustainability. Buying stock doesn't create a sustainable business and significant funds may be needed for the new plan to sustainability. We need to see the plan to sustainability which could take some time meaning ...more  
Comment by Hopeforthebest on Oct 04, 2024 12:08pm
What gagnon has failed to mentioned that under his leadership he has turned 1000 Zentaris share to less than 2 through several stock devaluations, under his leadership gagnon has drained the bank dry at Ceapro leaving little for product development, under gagnon's leadership he collected substantial monitary compensation as CEO Juvenite while  reducing overall sales to less than $30,000 ...more  
Comment by jrsloan60 on Oct 04, 2024 1:26pm
That sounds exactly right. I wished I could write it as well as you can. He's been promising things since I've been there as a shareholder. And I was there before he started. When they built a new plant and made it pharmaceutical grade, I thought the guy had a plan. Went to a few of the board meetings or the agms. Remember once he left early cuz he had to talk to somebody. Really important ...more  
Comment by Hopeforthebest on Oct 04, 2024 3:05pm
You do realize Stinzo that gagnon is out for only 1 person and that is the person he sees every morning in the mirror.gagnon does not know what the term shareholder values means and by doing something for the shareholders would only devalue what he is expecting for his next consultanting fee when he retires.
Comment by Stinzo on Oct 04, 2024 4:19pm
Then it is really beyond my understanding how such a scam can be permissible with the governing structure it has. The board of directors should have fired Gagnon many years ago. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities